LOG IN
Analysis
Featured Analysis
Articles by Category
Current Editions
Data Graphics
Discovery & Translation
Hot Topics
BioCentury Podcasts
Special Reports & Presentations
White Papers
BCIQ Data
BCIQ
Company Profiles
Product Profiles
Target Profiles
Financial Dashboards
Events
All Events
East-West Healthcare Reception
Bio€quity Europe
Grand Rounds — U.S.
Grand Rounds — Europe
China Healthcare Summit
East-West Biopharma Summit 2026
Bio€quity Europe 2026
Podcast: The BioCentury Show
Podcast: BioCentury This Week
Webinars
My Workspace
About BioCentury
Management
Analysts & Research Team
Scientific Advisory Board
Contact
Contact Us
Forgot Password
Request a Subscription
Sponsorship & Branding Inquiry
Media Kit
Request BioCentury's BCIQ Brochure
Customer Resource Center
Career Opportunities
Request a Trial
Company Profiles
Target Profiles
Product Profiles
Latest Articles
Commentaries
Deals
Distillery
Emerging Companies
Finance
Politics, Policy & Law
Product Development
Regulation
Targets & Mechanisms
Tools & Techniques
Company Profiles
Target Profiles
Product Profiles
China Healthcare Summit
Bio€quity Europe
Explore BCIQ profiles by entering a company name.
REQUEST A FREE TRIAL
Overview
Articles
Seragon Pharmaceuticals Inc.
Headquarters:
San Diego, CA, United States
Website:
N/A
Year Founded:
2013
Status:
Acquired
BioCentury
|
Oct 30, 2020
Product Development
José Baselga on how new modalities and biomarkers are shaping AZ’s oncology strategy
AZ’s oncology R&D head identifies priority technologies, targets and combination strategies
Read More
BioCentury
|
Aug 3, 2020
Finance
After raising crossover-heavy $70M round, p53 play PMV likely one of the next preclinical IPOs
Read More
BioCentury
|
Apr 4, 2020
Finance
Steady as venBio goes
venBio is staying the course with relatively small $394 million fund even as it moves away from strategic investors
Read More
BioCentury
|
Aug 9, 2019
Financial News
ORIC raises $55M to fund trials in drug-resistant cancers
Read More
BioCentury
|
Jul 13, 2018
Strategy
Roche’s partnering priority
Why Roche’s new combined partnering team will likely focus first on near-term growth drivers
Read More
BioCentury
|
Feb 2, 2018
Company News
Partner Therapeutics raises $60M, in-licenses Leukine
Read More
BioCentury
|
Feb 2, 2018
Financial News
Partner Therapeutics raises $60M, in-licenses Leukine
Read More
BioCentury
|
Feb 1, 2018
Company News
Roche halts SERD from Seragon, reports earnings
Read More
BioCentury
|
Jan 26, 2018
Company News
Management tracks: Partner Therapeutics, Merck
Read More
BioCentury
|
Apr 28, 2017
Clinical News
RG6046: Development discontinued
Read More
Items per page:
10
1 - 10 of 33